Fig. 2From: Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trialsForest plot depicting the relative risk of ARBs on a) all-cause mortality, b) myocardial infarction, and c) strokeBack to article page